<DOC>
	<DOCNO>NCT01375946</DOCNO>
	<brief_summary>A study evaluate pharmacokinetic profile , wearability safety AG200-15 , transdermal delivery levonorgestrel ( LNG ) ethinyl estradiol ( EE ) , normal condition external condition heat , humidity , cold water exercise .</brief_summary>
	<brief_title>Pharmacokinetic Study Of AGILE AG200-15 After Weekly Application Under Various Conditions Healthy Female Volunteers</brief_title>
	<detailed_description>Normal condition - average daily living activity , Dry Sauna - 10 minute 168.8 - 179.6 degree Fahrenheit , Whirlpool - 10 minute 102.2 - 105.8 degree Fahrenheit , Treadmill - 20 - 30 minute 60-80 % max heart rate , Cold Water - 5 - 15 minute 71.6 degree Fahrenheit . There three treatment period . Subjects randomly assign one five condition treatment period . The subject expose daily condition assign wear patch . The study patch wear 7 day treatment period , follow 7 day washout period . The total duration study 6 week .</detailed_description>
	<criteria>Healthy woman , age 1845 Body mass index ( BMI ) ≥18 less equal 32 , weight ≥ 110 lb . Willing use nonhormonal method contraception childbearing potential , already undergone previous bilateral tubal ligation hysterectomy Willing refrain use alcohol grapefruit juice 48 hour prior patch application completion treatment period Willing give inform consent participate study Known suspect pregnancy Breastfeeding within 1 month stop breastfeed Smokers Any disease may worsen hormonal treatment Hypersensitivity transdermal preparation sensitivity surgical/medical tape</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>Pharmacokinetic Profile ( PK ) Safety</keyword>
	<keyword>PK analysis EE LNG</keyword>
</DOC>